Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group
Wolfgang Eiermann, Erika Graf, Beyhan Ataseven, Bettina Conrad, Jörn Hilfrich, Heidi Massinger-Biebl, Sabine Vescia, Sibylle Loibl, Gunter von Minckwitz, Martin Schumacher, Manfred KaufmannVolume:
46
Année:
2010
Langue:
english
Pages:
95
DOI:
10.1016/j.ejca.2009.10.001
Fichier:
PDF, 665 KB
english, 2010
File converter
Plus de résultats de recherche
More benefits 
